Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 90 entries
Sorted by: Best Match Show Resources per page
Multi-Stage Feature Selection Based Intelligent Classifier for Classification of Incipient Stage Fire in Building.

Sensors (Basel, Switzerland)

Andrew AM, Zakaria A, Mad Saad S, Md Shakaff AY.
PMID: 26797617
Sensors (Basel). 2016 Jan 19;16(1). doi: 10.3390/s16010031.

In this study, an early fire detection algorithm has been proposed based on low cost array sensing system, utilising off- the shelf gas sensors, dust particles and ambient sensors such as temperature and humidity sensor. The odour or "smellprint"...

Cite
Andrew AM, Zakaria A, Mad Saad S, et al. Multi-Stage Feature Selection Based Intelligent Classifier for Classification of Incipient Stage Fire in Building. Sensors (Basel). 2016;16(1)doi: 10.3390/s16010031.
Andrew, A. M., Zakaria, A., Mad Saad, S., & Md Shakaff, A. Y. (2016). Multi-Stage Feature Selection Based Intelligent Classifier for Classification of Incipient Stage Fire in Building. Sensors (Basel, Switzerland), 16(1), . https://doi.org/10.3390/s16010031
Andrew, Allan Melvin, et al. "Multi-Stage Feature Selection Based Intelligent Classifier for Classification of Incipient Stage Fire in Building." Sensors (Basel, Switzerland) vol. 16,1 (2016). doi: https://doi.org/10.3390/s16010031
Andrew AM, Zakaria A, Mad Saad S, Md Shakaff AY. Multi-Stage Feature Selection Based Intelligent Classifier for Classification of Incipient Stage Fire in Building. Sensors (Basel). 2016 Jan 19;16(1). doi: 10.3390/s16010031. PMID: 26797617; PMCID: PMC4732064.
Copy Download .nbib Format: NLM
Fierce Advocates for Building All-Hazards Resurgence and Resilience: NYC Health + Hospitals' COVID-19 Experiences Applied.

Health security

Cagliuso NV, McGinty M, Madad S.
PMID: 32706596
Health Secur. 2020 Jul 24; doi: 10.1089/hs.2020.0100. Epub 2020 Jul 24.

No abstract available.

Cite
Cagliuso NV, McGinty M, Madad S. Fierce Advocates for Building All-Hazards Resurgence and Resilience: NYC Health + Hospitals' COVID-19 Experiences Applied. Health Secur. 2020;doi: 10.1089/hs.2020.0100.
Cagliuso, N. V., McGinty, M., & Madad, S. (2020). Fierce Advocates for Building All-Hazards Resurgence and Resilience: NYC Health + Hospitals' COVID-19 Experiences Applied. Health security, . https://doi.org/10.1089/hs.2020.0100
Cagliuso, Nicholas V, et al. "Fierce Advocates for Building All-Hazards Resurgence and Resilience: NYC Health + Hospitals' COVID-19 Experiences Applied." Health security vol. (2020). doi: https://doi.org/10.1089/hs.2020.0100
Cagliuso NV, McGinty M, Madad S. Fierce Advocates for Building All-Hazards Resurgence and Resilience: NYC Health + Hospitals' COVID-19 Experiences Applied. Health Secur. 2020 Jul 24; doi: 10.1089/hs.2020.0100. Epub 2020 Jul 24. PMID: 32706596.
Copy Download .nbib Format: NLM
Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes.

Frontiers in endocrinology

Hansen CS, Frandsen CS, Fleischer J, Vistisen D, Holst JJ, Tarnow L, Knop FK, Madsbad S, Andersen HU, Dejgaard TF.
PMID: 31031712
Front Endocrinol (Lausanne). 2019 Apr 12;10:242. doi: 10.3389/fendo.2019.00242. eCollection 2019.

The role of the autonomic nervous system in the efficacy of glucagon-like peptide-1 receptor agonists (GLP-1 RA) in patients with type 1 diabetes is unknown. We assessed the association between autonomic function and weight loss induced by the GLP-1...

Cite
Hansen CS, Frandsen CS, Fleischer J, et al. Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes. Front Endocrinol (Lausanne). 2019;10:242doi: 10.3389/fendo.2019.00242.
Hansen, C. S., Frandsen, C. S., Fleischer, J., Vistisen, D., Holst, J. J., Tarnow, L., Knop, F. K., Madsbad, S., Andersen, H. U., & Dejgaard, T. F. (2019). Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes. Frontiers in endocrinology, 10242. https://doi.org/10.3389/fendo.2019.00242
Hansen, Christian Stevns, et al. "Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes." Frontiers in endocrinology vol. 10 (2019): 242. doi: https://doi.org/10.3389/fendo.2019.00242
Hansen CS, Frandsen CS, Fleischer J, Vistisen D, Holst JJ, Tarnow L, Knop FK, Madsbad S, Andersen HU, Dejgaard TF. Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes. Front Endocrinol (Lausanne). 2019 Apr 12;10:242. doi: 10.3389/fendo.2019.00242. eCollection 2019. PMID: 31031712; PMCID: PMC6473101.
Copy Download .nbib Format: NLM
The Nutritional Status of Adult Antiretroviral Therapy Recipients with a Recent HIV Diagnosis; A Cross-Sectional Study in Primary Health Facilities in Gauteng, South Africa.

Healthcare (Basel, Switzerland)

Mahlangu K, Modjadji P, Madiba S.
PMID: 32846888
Healthcare (Basel). 2020 Aug 24;8(3). doi: 10.3390/healthcare8030290.

The study determined the nutritional status of adult antiretroviral therapy (ART) recipients, and investigated the association between the duration on ART and the nutritional status. This study was based in primary health facilities in Gauteng, South Africa. The data...

Cite
Mahlangu K, Modjadji P, Madiba S. The Nutritional Status of Adult Antiretroviral Therapy Recipients with a Recent HIV Diagnosis; A Cross-Sectional Study in Primary Health Facilities in Gauteng, South Africa. Healthcare (Basel). 2020;8(3)doi: 10.3390/healthcare8030290.
Mahlangu, K., Modjadji, P., & Madiba, S. (2020). The Nutritional Status of Adult Antiretroviral Therapy Recipients with a Recent HIV Diagnosis; A Cross-Sectional Study in Primary Health Facilities in Gauteng, South Africa. Healthcare (Basel, Switzerland), 8(3), . https://doi.org/10.3390/healthcare8030290
Mahlangu, Khabo, et al. "The Nutritional Status of Adult Antiretroviral Therapy Recipients with a Recent HIV Diagnosis; A Cross-Sectional Study in Primary Health Facilities in Gauteng, South Africa." Healthcare (Basel, Switzerland) vol. 8,3 (2020). doi: https://doi.org/10.3390/healthcare8030290
Mahlangu K, Modjadji P, Madiba S. The Nutritional Status of Adult Antiretroviral Therapy Recipients with a Recent HIV Diagnosis; A Cross-Sectional Study in Primary Health Facilities in Gauteng, South Africa. Healthcare (Basel). 2020 Aug 24;8(3). doi: 10.3390/healthcare8030290. PMID: 32846888; PMCID: PMC7551417.
Copy Download .nbib Format: NLM
Metabolic improvement after gastric bypass correlates with changes in IGF-regulatory proteins stanniocalcin-2 and IGFBP-4.

Metabolism: clinical and experimental

Hjortebjerg R, Bojsen-Møller KN, Søeby M, Oxvig C, Madsbad S, Frystyk J.
PMID: 34506805
Metabolism. 2021 Nov;124:154886. doi: 10.1016/j.metabol.2021.154886. Epub 2021 Sep 07.

BACKGROUND: Pregnancy-associated plasma protein-A (PAPP-A) is an enzyme that increases IGF-activity through cleavage of IGF-binding proteins (IGFBPs), primarily IGFBP-4, whereby bound IGF-I becomes released as a free molecule. The enzymatic activity of PAPP-A is irreversibly suppressed by the glycoprotein...

Cite
Hjortebjerg R, Bojsen-Møller KN, Søeby M, et al. Metabolic improvement after gastric bypass correlates with changes in IGF-regulatory proteins stanniocalcin-2 and IGFBP-4. Metabolism. 2021;124:154886doi: 10.1016/j.metabol.2021.154886.
Hjortebjerg, R., Bojsen-Møller, K. N., Søeby, M., Oxvig, C., Madsbad, S., & Frystyk, J. (2021). Metabolic improvement after gastric bypass correlates with changes in IGF-regulatory proteins stanniocalcin-2 and IGFBP-4. Metabolism: clinical and experimental, 124154886. https://doi.org/10.1016/j.metabol.2021.154886
Hjortebjerg, Rikke, et al. "Metabolic improvement after gastric bypass correlates with changes in IGF-regulatory proteins stanniocalcin-2 and IGFBP-4." Metabolism: clinical and experimental vol. 124 (2021): 154886. doi: https://doi.org/10.1016/j.metabol.2021.154886
Hjortebjerg R, Bojsen-Møller KN, Søeby M, Oxvig C, Madsbad S, Frystyk J. Metabolic improvement after gastric bypass correlates with changes in IGF-regulatory proteins stanniocalcin-2 and IGFBP-4. Metabolism. 2021 Nov;124:154886. doi: 10.1016/j.metabol.2021.154886. Epub 2021 Sep 07. PMID: 34506805.
Copy Download .nbib Format: NLM
Effects of 18-months metformin versus placebo in combination with three insulin regimens on RNA and DNA oxidation in individuals with type 2 diabetes: A post-hoc analysis of a randomized clinical trial.

Free radical biology & medicine

Larsen EL, Kjær LK, Lundby-Christensen L, Boesgaard TW, Breum L, Gluud C, Hedetoft C, Krarup T, Lund SS, Mathiesen ER, Perrild H, Sneppen SB, Tarnow L, Thorsteinsson B, Vestergaard H, Poulsen HE, Madsbad S, Almdal TP.
PMID: 34823018
Free Radic Biol Med. 2022 Jan;178:18-25. doi: 10.1016/j.freeradbiomed.2021.11.028. Epub 2021 Nov 22.

Formation of reactive oxygen species has been linked to the development of diabetes complications. Treatment with metformin has been associated with a lower risk of developing diabetes complications, including when used in combination with insulin. Metformin inhibits Complex 1...

Cite
Larsen EL, Kjær LK, Lundby-Christensen L, et al. Effects of 18-months metformin versus placebo in combination with three insulin regimens on RNA and DNA oxidation in individuals with type 2 diabetes: A post-hoc analysis of a randomized clinical trial. Free Radic Biol Med. 2021;178:18-25doi: 10.1016/j.freeradbiomed.2021.11.028.
Larsen, E. L., Kjær, L. K., Lundby-Christensen, L., Boesgaard, T. W., Breum, L., Gluud, C., Hedetoft, C., Krarup, T., Lund, S. S., Mathiesen, E. R., Perrild, H., Sneppen, S. B., Tarnow, L., Thorsteinsson, B., Vestergaard, H., Poulsen, H. E., Madsbad, S., & Almdal, T. P. (2022). Effects of 18-months metformin versus placebo in combination with three insulin regimens on RNA and DNA oxidation in individuals with type 2 diabetes: A post-hoc analysis of a randomized clinical trial. Free radical biology & medicine, 17818-25. https://doi.org/10.1016/j.freeradbiomed.2021.11.028
Larsen, Emil List, et al. "Effects of 18-months metformin versus placebo in combination with three insulin regimens on RNA and DNA oxidation in individuals with type 2 diabetes: A post-hoc analysis of a randomized clinical trial." Free radical biology & medicine vol. 178 (2022): 18-25. doi: https://doi.org/10.1016/j.freeradbiomed.2021.11.028
Larsen EL, Kjær LK, Lundby-Christensen L, Boesgaard TW, Breum L, Gluud C, Hedetoft C, Krarup T, Lund SS, Mathiesen ER, Perrild H, Sneppen SB, Tarnow L, Thorsteinsson B, Vestergaard H, Poulsen HE, Madsbad S, Almdal TP. Effects of 18-months metformin versus placebo in combination with three insulin regimens on RNA and DNA oxidation in individuals with type 2 diabetes: A post-hoc analysis of a randomized clinical trial. Free Radic Biol Med. 2022 Jan;178:18-25. doi: 10.1016/j.freeradbiomed.2021.11.028. Epub 2021 Nov 22. PMID: 34823018.
Copy Download .nbib Format: NLM
Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial.

Diabetologia

Thomsen MN, Skytte MJ, Samkani A, Carl MH, Weber P, Astrup A, Chabanova E, Fenger M, Frystyk J, Hartmann B, Holst JJ, Larsen TM, Madsbad S, Magkos F, Thomsen HS, Haugaard SB, Krarup T.
PMID: 34993571
Diabetologia. 2022 Jan 07; doi: 10.1007/s00125-021-05628-8. Epub 2022 Jan 07.

AIMS/HYPOTHESIS: Lifestyle modification and weight loss are cornerstones of type 2 diabetes management. However, carbohydrate restriction may have weight-independent beneficial effects on glycaemic control. This has been difficult to demonstrate because low-carbohydrate diets readily decrease body weight. We hypothesised...

Cite
Thomsen MN, Skytte MJ, Samkani A, et al. Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial. Diabetologia. 2022;doi: 10.1007/s00125-021-05628-8.
Thomsen, M. N., Skytte, M. J., Samkani, A., Carl, M. H., Weber, P., Astrup, A., Chabanova, E., Fenger, M., Frystyk, J., Hartmann, B., Holst, J. J., Larsen, T. M., Madsbad, S., Magkos, F., Thomsen, H. S., Haugaard, S. B., & Krarup, T. (2022). Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial. Diabetologia, . https://doi.org/10.1007/s00125-021-05628-8
Thomsen, Mads N, et al. "Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial." Diabetologia vol. (2022). doi: https://doi.org/10.1007/s00125-021-05628-8
Thomsen MN, Skytte MJ, Samkani A, Carl MH, Weber P, Astrup A, Chabanova E, Fenger M, Frystyk J, Hartmann B, Holst JJ, Larsen TM, Madsbad S, Magkos F, Thomsen HS, Haugaard SB, Krarup T. Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial. Diabetologia. 2022 Jan 07; doi: 10.1007/s00125-021-05628-8. Epub 2022 Jan 07. PMID: 34993571.
Copy Download .nbib Format: NLM
The emergence and transmission of COVID-19 in European countries, 2019-2020: a comprehensive review of timelines, cases and containment.

International health

Al-Salem W, Moraga P, Ghazi H, Madad S, Hotez PJ.
PMID: 34333650
Int Health. 2021 Sep 03;13(5):383-398. doi: 10.1093/inthealth/ihab037.

When it emerged in late 2019, COVID-19 was carried via travelers to Germany, France and Italy, where freedom of movement accelerated its transmission throughout Europe. However, effective non-pharmaceutical interventions introduced by European governments led to containment of the rapid...

Cite
Al-Salem W, Moraga P, Ghazi H, et al. The emergence and transmission of COVID-19 in European countries, 2019-2020: a comprehensive review of timelines, cases and containment. Int Health. 2021;13(5):383-398doi: 10.1093/inthealth/ihab037.
Al-Salem, W., Moraga, P., Ghazi, H., Madad, S., & Hotez, P. J. (2021). The emergence and transmission of COVID-19 in European countries, 2019-2020: a comprehensive review of timelines, cases and containment. International health, 13(5), 383-398. https://doi.org/10.1093/inthealth/ihab037
Al-Salem, Waleed, et al. "The emergence and transmission of COVID-19 in European countries, 2019-2020: a comprehensive review of timelines, cases and containment." International health vol. 13,5 (2021): 383-398. doi: https://doi.org/10.1093/inthealth/ihab037
Al-Salem W, Moraga P, Ghazi H, Madad S, Hotez PJ. The emergence and transmission of COVID-19 in European countries, 2019-2020: a comprehensive review of timelines, cases and containment. Int Health. 2021 Sep 03;13(5):383-398. doi: 10.1093/inthealth/ihab037. PMID: 34333650; PMCID: PMC8385807.
Copy Download .nbib Format: NLM
Neurotensin secretion after Roux-en-Y gastric bypass, sleeve gastrectomy, and truncal vagotomy with pyloroplasty.

Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society

Svane MS, Øhrstrøm CC, Plamboeck A, Jørgensen NB, Bojsen-Møller KN, Dirksen C, Martinussen C, Vilsbøll T, Hartmann B, Deacon CF, Kristiansen VB, Knop FK, Svendsen LB, Madsbad S, Holst JJ, Veedfald S.
PMID: 34378827
Neurogastroenterol Motil. 2022 Jan;34(1):e14210. doi: 10.1111/nmo.14210. Epub 2021 Aug 11.

OBJECTIVE: Neurotensin (NT) is released from enteroendocrine cells and lowers food intake in rodents. We evaluated postprandial NT secretion in humans after surgeries associated with accelerated small intestinal nutrient delivery, and after Roux-en-Y gastric bypass (RYGB) when glucagon-like peptide-1...

Cite
Svane MS, Øhrstrøm CC, Plamboeck A, et al. Neurotensin secretion after Roux-en-Y gastric bypass, sleeve gastrectomy, and truncal vagotomy with pyloroplasty. Neurogastroenterol Motil. 2021;34(1):e14210doi: 10.1111/nmo.14210.
Svane, M. S., Øhrstrøm, C. C., Plamboeck, A., Jørgensen, N. B., Bojsen-Møller, K. N., Dirksen, C., Martinussen, C., Vilsbøll, T., Hartmann, B., Deacon, C. F., Kristiansen, V. B., Knop, F. K., Svendsen, L. B., Madsbad, S., Holst, J. J., & Veedfald, S. (2022). Neurotensin secretion after Roux-en-Y gastric bypass, sleeve gastrectomy, and truncal vagotomy with pyloroplasty. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society, 34(1), e14210. https://doi.org/10.1111/nmo.14210
Svane, Maria S, et al. "Neurotensin secretion after Roux-en-Y gastric bypass, sleeve gastrectomy, and truncal vagotomy with pyloroplasty." Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society vol. 34,1 (2022): e14210. doi: https://doi.org/10.1111/nmo.14210
Svane MS, Øhrstrøm CC, Plamboeck A, Jørgensen NB, Bojsen-Møller KN, Dirksen C, Martinussen C, Vilsbøll T, Hartmann B, Deacon CF, Kristiansen VB, Knop FK, Svendsen LB, Madsbad S, Holst JJ, Veedfald S. Neurotensin secretion after Roux-en-Y gastric bypass, sleeve gastrectomy, and truncal vagotomy with pyloroplasty. Neurogastroenterol Motil. 2022 Jan;34(1):e14210. doi: 10.1111/nmo.14210. Epub 2021 Aug 11. PMID: 34378827.
Copy Download .nbib Format: NLM
Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump-treated type 1 diabetes.

Diabetes, obesity & metabolism

Schmidt S, Frandsen CS, Dejgaard TF, Vistisen D, Halldórsson T, Olsen SF, Jensen JB, Madsbad S, Andersen HU, Nørgaard K.
PMID: 34595827
Diabetes Obes Metab. 2021 Sep 30; doi: 10.1111/dom.14567. Epub 2021 Sep 30.

AIMS: To present secondary outcome analyses of liraglutide treatment in overweight adults with insulin pump-treated type 1 diabetes (T1D), focusing on changes in body composition and dimensions, and to evaluate changes in food intake to identify potential dietary drivers...

Cite
Schmidt S, Frandsen CS, Dejgaard TF, et al. Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump-treated type 1 diabetes. Diabetes Obes Metab. 2021;doi: 10.1111/dom.14567.
Schmidt, S., Frandsen, C. S., Dejgaard, T. F., Vistisen, D., Halldórsson, T., Olsen, S. F., Jensen, J. B., Madsbad, S., Andersen, H. U., & Nørgaard, K. (2021). Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump-treated type 1 diabetes. Diabetes, obesity & metabolism, . https://doi.org/10.1111/dom.14567
Schmidt, Signe, et al. "Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump-treated type 1 diabetes." Diabetes, obesity & metabolism vol. (2021). doi: https://doi.org/10.1111/dom.14567
Schmidt S, Frandsen CS, Dejgaard TF, Vistisen D, Halldórsson T, Olsen SF, Jensen JB, Madsbad S, Andersen HU, Nørgaard K. Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump-treated type 1 diabetes. Diabetes Obes Metab. 2021 Sep 30; doi: 10.1111/dom.14567. Epub 2021 Sep 30. PMID: 34595827.
Copy Download .nbib Format: NLM
Truth, Deception, and Coercion; Communication Strategies Used by Caregivers of Children with Perinatally Acquired HIV During the Pre-Disclosure and Post-Disclosure Period in Rural Communities in South Africa.

Global pediatric health

Molokwane M, Madiba S.
PMID: 34104705
Glob Pediatr Health. 2021 May 31;8:2333794X211022269. doi: 10.1177/2333794X211022269. eCollection 2021.

Typically, children with perinatal HIV (PHIV) receive antiretroviral treatment (ART) for a long time prior to receiving disclosure. Communication with children about HIV and treatment is critical for monitoring adherence and retention in care. However, there is a dearth...

Cite
Molokwane M, Madiba S. Truth, Deception, and Coercion; Communication Strategies Used by Caregivers of Children with Perinatally Acquired HIV During the Pre-Disclosure and Post-Disclosure Period in Rural Communities in South Africa. Glob Pediatr Health. 2021;8:2333794X211022269doi: 10.1177/2333794X211022269.
Molokwane, M., & Madiba, S. (2021). Truth, Deception, and Coercion; Communication Strategies Used by Caregivers of Children with Perinatally Acquired HIV During the Pre-Disclosure and Post-Disclosure Period in Rural Communities in South Africa. Global pediatric health, 82333794X211022269. https://doi.org/10.1177/2333794X211022269
Molokwane, Mmathale, and Madiba, Sphiwe. "Truth, Deception, and Coercion; Communication Strategies Used by Caregivers of Children with Perinatally Acquired HIV During the Pre-Disclosure and Post-Disclosure Period in Rural Communities in South Africa." Global pediatric health vol. 8 (2021): 2333794X211022269. doi: https://doi.org/10.1177/2333794X211022269
Molokwane M, Madiba S. Truth, Deception, and Coercion; Communication Strategies Used by Caregivers of Children with Perinatally Acquired HIV During the Pre-Disclosure and Post-Disclosure Period in Rural Communities in South Africa. Glob Pediatr Health. 2021 May 31;8:2333794X211022269. doi: 10.1177/2333794X211022269. eCollection 2021. PMID: 34104705; PMCID: PMC8170273.
Copy Download .nbib Format: NLM
Nonalcoholic Fatty Liver Disease Impairs the Liver-Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis.

Hepatology communications

Pedersen JS, Rygg MO, Kristiansen VB, Olsen BH, Serizawa RR, Holst JJ, Madsbad S, Gluud LL, Bendtsen F, Wewer Albrechtsen NJ.
PMID: 33163832
Hepatol Commun. 2020 Sep 01;4(11):1610-1623. doi: 10.1002/hep4.1562. eCollection 2020 Nov.

Nonalcoholic fatty liver disease (NAFLD) is associated with impaired hepatic actions of glucagon and insulin. Glucagon and amino acids are linked in an endocrine feedback circuit, the liver-alpha cell axis, that may be disrupted by NAFLD. We investigated how...

Cite
Pedersen JS, Rygg MO, Kristiansen VB, et al. Nonalcoholic Fatty Liver Disease Impairs the Liver-Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis. Hepatol Commun. 2020;4(11):1610-1623doi: 10.1002/hep4.1562.
Pedersen, J. S., Rygg, M. O., Kristiansen, V. B., Olsen, B. H., Serizawa, R. R., Holst, J. J., Madsbad, S., Gluud, L. L., Bendtsen, F., & Wewer Albrechtsen, N. J. (2020). Nonalcoholic Fatty Liver Disease Impairs the Liver-Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis. Hepatology communications, 4(11), 1610-1623. https://doi.org/10.1002/hep4.1562
Pedersen, Julie Steen, et al. "Nonalcoholic Fatty Liver Disease Impairs the Liver-Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis." Hepatology communications vol. 4,11 (2020): 1610-1623. doi: https://doi.org/10.1002/hep4.1562
Pedersen JS, Rygg MO, Kristiansen VB, Olsen BH, Serizawa RR, Holst JJ, Madsbad S, Gluud LL, Bendtsen F, Wewer Albrechtsen NJ. Nonalcoholic Fatty Liver Disease Impairs the Liver-Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis. Hepatol Commun. 2020 Sep 01;4(11):1610-1623. doi: 10.1002/hep4.1562. eCollection 2020 Nov. PMID: 33163832; PMCID: PMC7603528.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 90 entries